The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

NCT03641352 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: CKD-501 0.5mg
DRUG: Placebo

Sponsor

Chong Kun Dang Pharmaceutical